
Cardiologists Keep Backing Anti-Inflammatory Drugs After Novo Trial Setback
STAT reports heart specialists remain committed to anti-inflammatory treatments even after a Novo drug failed in a major trial.
Nov 7, 2026 · 1 min read
138 views
Doctor | Kazan, Russia | Passionate about Tech

STAT reports heart specialists remain committed to anti-inflammatory treatments even after a Novo drug failed in a major trial.